Cargando…
Could exercise hormone irisin be a therapeutic agent against Parkinson’s and other neurodegenerative diseases?
Parkinson’s disease (PD) is the second most common neurodegenerative disease after Alzheimer’s disease (AD). The pathologic hallmarks of the disease are the loss of dopaminergic neurons of substantia nigra pars compacta and the presence of intraneuronal alpha synuclein (a-syn) aggregates. Clinical f...
Autores principales: | Avgerinos, Konstantinos I., Liu, Junli, Dalamaga, Maria |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9918419/ https://www.ncbi.nlm.nih.gov/pubmed/36785617 http://dx.doi.org/10.1016/j.metop.2023.100233 |
Ejemplares similares
-
Could gut mycobiome play a role in NAFLD pathogenesis? Insights and therapeutic perspectives
por: Fotis, Dimitrios, et al.
Publicado: (2022) -
Could hyperglycemia-induced cardiac autoimmunity be hidden behind cardiovascular disease in type 1 diabetes mellitus?
por: Vallianou, Natalia, et al.
Publicado: (2019) -
Irisin and the therapeutic benefits of exercise
por: Spiegelman, Bruce M, et al.
Publicado: (2012) -
Exercise hormone irisin is a critical regulator of cognitive function
por: Islam, Mohammad R., et al.
Publicado: (2021) -
Metabolism Open: A new journal in the quest of the golden fleece in metabolic research
por: Dalamaga, Maria, et al.
Publicado: (2019)